Corden Pharma Chenove is an API manufacturer based in France. It holds 7 active US drug master files across a filed portfolio of 6 molecules. Its GMP standing is certified by ANSM (FR), EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 14 February 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| France, France | 3002808295 |
| Chenove, France | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Fenofibrate | SFDA (Saudi Arabia), US FDA | 3 |
| Bisoprolol | US FDA | 1 |
| Choline Salicylate | US FDA | 1 |
| Nebivolol | US FDA | 1 |
| Oxybutynin | US FDA | 1 |
| Tetrabenazine | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ANSM (FR) | None | 17 |
| EMA | None | 2 |
| US FDA | None | 1 |
Choose your molecules and target markets. Corden Pharma Chenove comes back tiered against every other supplier able to file there.
Start for free